<div>
  <ul>
    <li>
      <p>
        FemTec Health, a health and beauty sciences company, has announced the acquisition of Ava AG (known as Ava, Ava Women), an FDA-cleared fertility tracking platform, for an undisclosed amount.
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        Founded in 2014, Ava offers a wearable and complementing app, which attempts to monitor women&rsquo;s menstrual cycles. It distinguishes itself from market alternatives by combining hardware with analytical software and by using a vast range of bodily metrics to determine ovulation. Unlike most kits, which use only body temperature to assess ovulation, Ava collects nine diagnostics through its bracelet, including heart rate, pulse rate, heat loss, and sleep movements. Ava is sold in 36 countries and has assisted in over 70,000 pregnancies.
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        Ava&rsquo;s AI technology will be integrated with the FemTec Health platform to allow existing Ava users and Awesome Woman subscribers access to Ava's at-home fertility monitoring, data-driven health insights, weekly pregnancy information, and community resources, along with FemTec Health&rsquo;s Awesome Woman on-demand telehealth services, at-home diagnostics, monthly subscription boxes, wellness products, prescription delivery, educational content, and stress management tools.
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        Founded in 2020, FemTec Health leverages state-of-the-art genomics, predictive intelligence, and digital technologies to provide Awesome Woman health solutions through monthly subscriptions either directly to consumers or as part of an employer's health benefit plan. Awesome Woman health now offers subscriptions for urinary and vaginal health, hormone balance, sexual wellness, wellness and prevention, beauty, and reproductive health.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/femtec-health-acquires-ava-ag-reproductive-monitoring-pioneer-301589160.html">
      Company press release
    </a>
  </p>
  <p>
    <a href="https://www.venturelab.swiss/Ava-gets-acquired-by-FemTec-Health">
      Venturelab
    </a>
  </p>
</div>


Fertility Tech

FemTec Health acquires AVA to expand into reproductive health

DISRUPTOR_PRESENT

PROMINENT_CATEGORY

Home fertility solutions startup, Mosie Baby, has secured more than $1 million in a bridge round, surpassing its target and bringing its total funding to $1.2 million. Investors in the round include Magic Fund, The Fund Everywhere, The Council, and 37 Angels. The funds will be used to expand the company's retail partnerships and launch its kits with CVS and other mass retailers. Additionally, Mosie Baby has unveiled an updated home insemination kit that features patented Mosie Syringes and collection cups for semen collection and transfer.

Mosie Baby raises ~USD 1 million in bridge funding

Fertilly launches dry blood method home fertility test kit

Pinnacle Fertility adds Oma Fertility clinics to expand network

Progyny announces Q2 FY2023 earnings; beats analyst estimates

Bea Fertility raises GBP 2.5 million

Cofertility partners with TMRW Life Sciences

Fertifa raises GBP 5 million in seed funding

Oova raises USD 10.3 million in Series A funding

Twig Fertility raises CAD 8 million in Series A funding

Mate Fertility raises USD 5.2 million in Series A funding

All Updates